Dr. Arthur Greyf
Chief Medical Officer
Arthur Greyf DDS FICOI is Osseoprint 3D’s CEO and Chief Medical Officer. Arthur is a renowned implantologist who has dedicated most of his career to streamlining the implant process and improving patient outcomes. Dr. Greyf developed much of OsseoPrint 3D’s medical IP and is widely sought by patients from around the world. Dr. Greyf is also a former clinical professor at SUNY Downstate.
Alex Natanzon, Ph.D.
Chief Technology Officer
Alex Natanzon is a renowned bio-medical technology leader, inventor and entrepreneur. He stands behind the first commercial PET medical scanner - currently the main tool for early cancer diagnosis. His algorithms, inventions and leadership resulted in the first in the world robot for lumbar spinal surgeries. He served as VP of GE Healthcare IT following acquisition of his startup. Author of more than 20 US patents and 40 scientific papers in Physics and Engineering.
Joachim Kohn, PhD, FBSE
Former Chief Scientific Advisor 2021-2024
Dr. Kohn is Distinguished Professor Emeritus of the Chemistry and Chemical Biology Department at the School of Arts and Sciences, Rutgers University and former director of the New Jersey Center of Biomaterials.
He specializes in biocompatible polymers and holds 80 US patents. He is a three-time recipient of the Edison Award for the best medical technology patent in New Jersey.
